Archer-Daniels-Midland (ADM) Earnings Analysis

Archer-Daniels-Midland (ADM) delivered mixed results in FY2026 on revenue of $130.6B versus the $132.2B estimate (+10.6% YoY) and EPS of $3.92. Below is the full Archer-Daniels-Midland earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Archer-Daniels-Midland (ADM) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$130.6B (vs $132.2B est · -1.2% surprise · +10.6% YoY)
EPS$3.92 (vs $3.75 est · +4.5% surprise · +9.4% YoY)
Share price$381.93 (-1.9%)
Market cap$2.03T

What you'll find

Frequently asked questions

When is Archer-Daniels-Midland's next earnings date?
Archer-Daniels-Midland's (ADM) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Archer-Daniels-Midland (ADM) beat or miss earnings?
In FY2026, Archer-Daniels-Midland (ADM) posted mixed results — revenue of $130.6B versus the $132.2B estimate (-1.2% surprise) and EPS of $3.92 versus $3.75 expected (+4.5% surprise). Magnisto decodes every Archer-Daniels-Midland (ADM) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Archer-Daniels-Midland (ADM) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Archer-Daniels-Midland (ADM), anchored to the current $381.93 share price, so you can weigh the bull, base and bear cases for Archer-Daniels-Midland side by side.
Is Archer-Daniels-Midland (ADM) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Archer-Daniels-Midland fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.